×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 26: Changes Reportable in an Annual Report
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Components and Composition
- Manufacturing Sites and Process
- Specifications
- Container/Closure System
Have an account?